Skip to main content

Formulate

Find pharma jobs. Prep for interviews like no one else can.

Browse

Jobs Companies Drugs Indications Career Advisor About

Insider Intel

Intelligence Hub Therapeutic Areas Contribute Intro Network Salary Explorer For Employers Pricing

Legal

Privacy Policy Terms of Service About Our Crawler Content Removal Your Privacy Choices

© 2026 Formulate. Pharma Jobs with Drug Intelligence.

Metabolic Diseases Jobs in Biotech & Pharma | Formulate

Metabolic Diseases Jobs

392 open positions in metabolic diseases

Oncology Immunology Neurology Rare Diseases Infectious Diseases Cardiovascular Gene Therapy Cell Therapy

Senior QA Manager (Quality Systems)

Dexcom

Posted 2mo ago

Athenry, Ireland (Flex)

Full-time

Condition in scope: Diabetes Mellitus

Quality AssuranceMetabolic DiseasesSenior

H-1B · 1 FY23

Computational Scientist (Mass Spectrometry)

Axiom

Posted 2mo ago

SF Global HQ

Full-time

GeneralMetabolic DiseasesMID

Territory Manager, BBS (Northwest)

Rhythm Pharmaceuticals

Posted 2mo ago

$135K - $215K

Related drug: IMCIVREE

CommercialMetabolic DiseasesMANAGER

H-1B · 1 FY23

Studentische Aushilfe (m/w/d) - Healthcare Strategic Sales

Dexcom

Posted 2mo ago

Mainz, Germany (Assigned Desk)

Part-time

Condition in scope: Diabetes Mellitus

CommercialMetabolic DiseasesMID

H-1B · 1 FY23

Sr Equipment Engineer (Onsite - Acton, MA)

Insulet

Posted 2mo ago

Acton, Massachusetts (Onsite)

$106K - $159K

Full-time

EngineeringMetabolic DiseasesSenior

H-1B · 10 FY23

M&S Graduate Program- IFB Quality Assurance Manager - Beijing

Sanofi

Posted 2mo ago

Beijing

Full-time

Quality AssuranceMetabolic DiseasesMANAGER

H-1B · 1 FY23

Principal Electrical Engineer (Hybrid - Acton, MA)

Insulet

Posted 2mo ago

Acton, Massachusetts (Hybrid)

$163K - $244K

Full-time

EngineeringMetabolic DiseasesSenior

H-1B · 10 FY23

Senior Staff SW Systems Engineer - Mobile Apps

Dexcom

Posted 2mo ago

Remote

$149K - $248K

Full-time

Condition in scope: Diabetes Mellitus

RemoteEngineeringMetabolic DiseasesSenior

H-1B · 1 FY23

Pharmaziepraktikant*in im Bereich FBC API (Insulin Wirkstoffproduktion) für Mai 2028

Sanofi

Posted 2mo ago

Frankfurt am Main

Full-time

Metabolic DiseasesMID

H-1B · 1 FY23

Customer Identity Engineer

Insulet

Posted 2mo ago

United Kingdom (London - Office), GB (Hybrid)

Full-time

EngineeringMetabolic DiseasesMID

H-1B · 10 FY23

Executive Director / Vice President, Biology & Translational Pharmacology

Profluent

Posted 2mo ago

Emeryville, California, United States; On-site

$270K - $340K

BiologyMetabolic DiseasesExecutive

Program Manager - AI Initiatives

Dexcom

Posted 2mo ago

Taguig, Philippines (Flex)

Full-time

Condition in scope: Diabetes Mellitus

Project ManagementMetabolic DiseasesMANAGER

H-1B · 1 FY23

Sr Associate Scientist, Histology

Regeneron

Posted 2mo ago

TARRYTOWN

$80K - $131K

Full-time

Condition in scope: Obesity

Research & DevelopmentMetabolic DiseasesSenior

H-1B · 1 FY23

Medical Science Liaison, Field Medical Affairs (Regional Medical Liaison) (Greater Texas)

Kailera Therapeutics

Posted 3mo ago

Remote

$196K - $235K

Condition in scope: Obesity

RemoteMedical AffairsMetabolic DiseasesMID

Pracownik/ca produkcyjny/a

Molecular Devices

Posted 3mo ago

Stargard, Poland

Full-time

Metabolic DiseasesMID

H-1B · 1 FY23

Pracownik/ca produkcyjny/a

Danaher

Posted 3mo ago

Stargard, Poland

Full-time

Metabolic DiseasesMID

H-1B · 8 FY23

Pracownik/ca produkcyjny/a

Phenomenex

Posted 3mo ago

Stargard, Poland

Full-time

Metabolic DiseasesMID

Professional (Senior) Sales Representative, Pain - Nashville N, TN

Viatris

Posted 3mo ago

Remote

$100K - $150K

Full-time

RemoteCommercialMetabolic DiseasesSenior

H-1B · 5 FY23

Professional (Senior) Sales Representative, Pain - Nashville S, TN

Viatris

Posted 3mo ago

Remote

$100K - $150K

Full-time

RemoteCommercialMetabolic DiseasesSenior

H-1B · 5 FY23

Commercialization Leader - Emerging Care Settings

Becton Dickinson

Posted 3mo ago

USA NJ - Franklin Lakes (Onsite)

$166K - $266K

Full-time

ManufacturingMetabolic DiseasesMID

H-1B · 2 FY23

Previous
1
16
17
18
20
Next